Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe

Kissling, Esther; Hooiveld, Mariette; Martinez-Baz, Ivan; Mazagatos, Clara; William, Naoma; Vilcu, Ana Maria; Kooijman, Marjolein N.; Ilic, Maja; Domegan, Lisa; Machado, Ausenda; De Lusignan, Simon; Lazar, Mihaela; Meijer, Adam; Brytting, Mia; Casado, Itziar; Larrauri, Amparo; Murray, Josephine L.K.; Behillil, Sylvie; De Gier, Brechje; Mlinaric, Ivan; O'Donnell, Joan; Rodrigues, Ana Paula; Tsang, Ruby; Timnea, Olivia; De Lange, Marit; Riess, Maximilian; Castilla, Jesus; Pozo, Francisco; Hamilton, Mark; Falchi, Alessandra; Knol, Mirjam J.; Filipovic, Sanja Kurecic; Dunford, Linda; Guiomar, Raquel; Cogdale, Jade; Cherciu, Carmen; Jansen, Tessa; Enkirch, Theresa; Basile, Luca; Connell, Jeff; Gomez, Veronica; Martin, Virginia Sandonis; Bacci, Sabrina; Rose, Angela M.C.; Celentano, Lucia Pastore; Valenciano, Marta; Kislaya, Irina; Nunes, Baltazar

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe

Detalhes bibliográficos
Autor(a) principal:	Kissling, Esther
Data de Publicação:	2022
Outros Autores:	Hooiveld, Mariette, Martinez-Baz, Ivan, Mazagatos, Clara, William, Naoma, Vilcu, Ana Maria, Kooijman, Marjolein N., Ilic, Maja, Domegan, Lisa, Machado, Ausenda, De Lusignan, Simon, Lazar, Mihaela, Meijer, Adam, Brytting, Mia, Casado, Itziar, Larrauri, Amparo, Murray, Josephine L.K., Behillil, Sylvie, De Gier, Brechje, Mlinaric, Ivan, O'Donnell, Joan, Rodrigues, Ana Paula, Tsang, Ruby, Timnea, Olivia, De Lange, Marit, Riess, Maximilian, Castilla, Jesus, Pozo, Francisco, Hamilton, Mark, Falchi, Alessandra, Knol, Mirjam J., Filipovic, Sanja Kurecic, Dunford, Linda, Guiomar, Raquel, Cogdale, Jade, Cherciu, Carmen, Jansen, Tessa, Enkirch, Theresa, Basile, Luca, Connell, Jeff, Gomez, Veronica, Martin, Virginia Sandonis, Bacci, Sabrina, Rose, Angela M.C., Celentano, Lucia Pastore, Valenciano, Marta, Kislaya, Irina, Nunes, Baltazar
Tipo de documento:	Artigo
Idioma:	eng
Título da fonte:	Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo:	http://hdl.handle.net/10362/149492
Resumo:	Funding Information: This project received funding from the European Centre for Disease Prevention and Control (ECDC) under the contract ECD.11486. Funding Information: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003673. Publisher Copyright: © 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.

Metadados do item

id	RCAP_e555d1d455b07d25ff2dcc9a9ca06142
oai_identifier_str	oai:run.unl.pt:10362/149492
network_acronym_str	RCAP
network_name_str	Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str	7160
spelling	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europemulticentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021EpidemiologyPublic Health, Environmental and Occupational HealthVirologySDG 3 - Good Health and Well-beingFunding Information: This project received funding from the European Centre for Disease Prevention and Control (ECDC) under the contract ECD.11486. Funding Information: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003673. Publisher Copyright: © 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.Introduction: In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using a multicentre test-negative study, we measured COVID-19 vaccine effectiveness (VE) against symptomatic infection. Methods: Individuals with COVID-19 or acute respiratory symptoms at primary care/community level in 10 European countries were tested for SARS-CoV-2. We measured complete primary course overall VE by vaccine brand and by time since vaccination. Results: Overall VE was 74% (95% CI: 69-79), 76% (95% CI: 71-80), 63% (95% CI: 48-75) and 63% (95% CI: 16-83) among those aged 30-44, 45-59, 60-74 and ≥ 75 years, respectively. VE among those aged 30-59 years was 78% (95% CI: 75-81), 66% (95% CI: 58-73), 91% (95% CI: 87-94) and 52% (95% CI: 40-61), for Comirnaty, Vaxzevria, Spikevax and COVID-19 Vaccine Janssen, respectively. VE among people 60 years and older was 67% (95% CI: 52-77), 65% (95% CI: 48-76) and 83% (95% CI: 64-92) for Comirnaty, Vaxzevria and Spikevax, respectively. Comirnaty VE among those aged 30-59 years was 87% (95% CI: 83-89) at 14-29 days and 65% (95% CI: 56-71%) at ≥ 90 days between vaccination and onset of symptoms. Conclusions: VE against symptomatic infection with the SARS-CoV-2 Delta variant varied among brands, ranging from 52% to 91%. While some waning of the vaccine effect may be present (sample size limited this analysis to only Comirnaty), protection was 65% at 90 days or more between vaccination and onset.Escola Nacional de Saúde Pública (ENSP)RUNKissling, EstherHooiveld, MarietteMartinez-Baz, IvanMazagatos, ClaraWilliam, NaomaVilcu, Ana MariaKooijman, Marjolein N.Ilic, MajaDomegan, LisaMachado, AusendaDe Lusignan, SimonLazar, MihaelaMeijer, AdamBrytting, MiaCasado, ItziarLarrauri, AmparoMurray, Josephine L.K.Behillil, SylvieDe Gier, BrechjeMlinaric, IvanO'Donnell, JoanRodrigues, Ana PaulaTsang, RubyTimnea, OliviaDe Lange, MaritRiess, MaximilianCastilla, JesusPozo, FranciscoHamilton, MarkFalchi, AlessandraKnol, Mirjam J.Filipovic, Sanja KurecicDunford, LindaGuiomar, RaquelCogdale, JadeCherciu, CarmenJansen, TessaEnkirch, TheresaBasile, LucaConnell, JeffGomez, VeronicaMartin, Virginia SandonisBacci, SabrinaRose, Angela M.C.Celentano, Lucia PastoreValenciano, MartaKislaya, IrinaNunes, Baltazar2023-02-20T22:20:29Z2022-05-262022-05-26T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/149492eng1025-496XPURE: 53859097https://doi.org/10.2807/1560-7917.ES.2022.27.21.2101104info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:31:23Zoai:run.unl.pt:10362/149492Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:53:45.890502Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
title	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe
spellingShingle	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe Kissling, Esther Epidemiology Public Health, Environmental and Occupational Health Virology SDG 3 - Good Health and Well-being
title_short	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe
title_full	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe
title_fullStr	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe
title_full_unstemmed	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe
title_sort	Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe
author	Kissling, Esther
author_facet	Kissling, Esther Hooiveld, Mariette Martinez-Baz, Ivan Mazagatos, Clara William, Naoma Vilcu, Ana Maria Kooijman, Marjolein N. Ilic, Maja Domegan, Lisa Machado, Ausenda De Lusignan, Simon Lazar, Mihaela Meijer, Adam Brytting, Mia Casado, Itziar Larrauri, Amparo Murray, Josephine L.K. Behillil, Sylvie De Gier, Brechje Mlinaric, Ivan O'Donnell, Joan Rodrigues, Ana Paula Tsang, Ruby Timnea, Olivia De Lange, Marit Riess, Maximilian Castilla, Jesus Pozo, Francisco Hamilton, Mark Falchi, Alessandra Knol, Mirjam J. Filipovic, Sanja Kurecic Dunford, Linda Guiomar, Raquel Cogdale, Jade Cherciu, Carmen Jansen, Tessa Enkirch, Theresa Basile, Luca Connell, Jeff Gomez, Veronica Martin, Virginia Sandonis Bacci, Sabrina Rose, Angela M.C. Celentano, Lucia Pastore Valenciano, Marta Kislaya, Irina Nunes, Baltazar
author_role	author
author2	Hooiveld, Mariette Martinez-Baz, Ivan Mazagatos, Clara William, Naoma Vilcu, Ana Maria Kooijman, Marjolein N. Ilic, Maja Domegan, Lisa Machado, Ausenda De Lusignan, Simon Lazar, Mihaela Meijer, Adam Brytting, Mia Casado, Itziar Larrauri, Amparo Murray, Josephine L.K. Behillil, Sylvie De Gier, Brechje Mlinaric, Ivan O'Donnell, Joan Rodrigues, Ana Paula Tsang, Ruby Timnea, Olivia De Lange, Marit Riess, Maximilian Castilla, Jesus Pozo, Francisco Hamilton, Mark Falchi, Alessandra Knol, Mirjam J. Filipovic, Sanja Kurecic Dunford, Linda Guiomar, Raquel Cogdale, Jade Cherciu, Carmen Jansen, Tessa Enkirch, Theresa Basile, Luca Connell, Jeff Gomez, Veronica Martin, Virginia Sandonis Bacci, Sabrina Rose, Angela M.C. Celentano, Lucia Pastore Valenciano, Marta Kislaya, Irina Nunes, Baltazar
author2_role	author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author
dc.contributor.none.fl_str_mv	Escola Nacional de Saúde Pública (ENSP) RUN
dc.contributor.author.fl_str_mv	Kissling, Esther Hooiveld, Mariette Martinez-Baz, Ivan Mazagatos, Clara William, Naoma Vilcu, Ana Maria Kooijman, Marjolein N. Ilic, Maja Domegan, Lisa Machado, Ausenda De Lusignan, Simon Lazar, Mihaela Meijer, Adam Brytting, Mia Casado, Itziar Larrauri, Amparo Murray, Josephine L.K. Behillil, Sylvie De Gier, Brechje Mlinaric, Ivan O'Donnell, Joan Rodrigues, Ana Paula Tsang, Ruby Timnea, Olivia De Lange, Marit Riess, Maximilian Castilla, Jesus Pozo, Francisco Hamilton, Mark Falchi, Alessandra Knol, Mirjam J. Filipovic, Sanja Kurecic Dunford, Linda Guiomar, Raquel Cogdale, Jade Cherciu, Carmen Jansen, Tessa Enkirch, Theresa Basile, Luca Connell, Jeff Gomez, Veronica Martin, Virginia Sandonis Bacci, Sabrina Rose, Angela M.C. Celentano, Lucia Pastore Valenciano, Marta Kislaya, Irina Nunes, Baltazar
dc.subject.por.fl_str_mv	Epidemiology Public Health, Environmental and Occupational Health Virology SDG 3 - Good Health and Well-being
topic	Epidemiology Public Health, Environmental and Occupational Health Virology SDG 3 - Good Health and Well-being
description	Funding Information: This project received funding from the European Centre for Disease Prevention and Control (ECDC) under the contract ECD.11486. Funding Information: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003673. Publisher Copyright: © 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
publishDate	2022
dc.date.none.fl_str_mv	2022-05-26 2022-05-26T00:00:00Z 2023-02-20T22:20:29Z
dc.type.status.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv	info:eu-repo/semantics/article
format	article
status_str	publishedVersion
dc.identifier.uri.fl_str_mv	http://hdl.handle.net/10362/149492
url	http://hdl.handle.net/10362/149492
dc.language.iso.fl_str_mv	eng
language	eng
dc.relation.none.fl_str_mv	1025-496X PURE: 53859097 https://doi.org/10.2807/1560-7917.ES.2022.27.21.2101104
dc.rights.driver.fl_str_mv	info:eu-repo/semantics/openAccess
eu_rights_str_mv	openAccess
dc.format.none.fl_str_mv	application/pdf
dc.source.none.fl_str_mv	reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP
instname_str	Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str	RCAAP
institution	RCAAP
reponame_str	Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection	Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv	Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_	1799138127368945664

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe

Registros relacionados